The optimal timing for valvular heart disease surgery requires balancing surgical risks against the potential for irreversible cardiac damage, depending on defect severity and symptoms.
May inform individualized valvular surgery timing; leaves open need for prospective trials to define thresholds.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Reginelli et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: